tirzepatide glp Associated with Lower POAG, OHT Risk Compared with Other GLP-1 Drugs Tirzepatide | DirectMeds

Pese a su creciente popularidad, estos frmacos para adelgazar han generado debate por los efectos secundarios que pueden provocar, como problemas gastrointestinales graves, segn seal un estudio publicado el ao pasado en la revista Journal of the American Medical Association (JAMA)

International Journal of Clinical Pharmacy

Enhanced Insulin Secretion: Activation of both GIP and GLP-1 receptors stimulates glucose-dependent insulin release from pancreatic -cells, improving postprandial and fasting glycemia while minimizing the risk of hypoglycemia

For example, obese diabetics are a special case and should not be given the full mortality and morbidity benefit for the weight-loss indication in addition to the diabetes indication

Dispose Safely: Dispose of needles in a sharps container

This doesn't mean the medication has failed